ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) shares passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $17.21 and traded as high as $22.59. ChronoScale Corporation Common Stock shares last traded at $17.64, with a volume of 805,758 shares traded.
Analyst Ratings Changes
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research note on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $6.00.
Check Out Our Latest Report on ChronoScale Corporation Common Stock
ChronoScale Corporation Common Stock Stock Performance
ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) last issued its quarterly earnings results on Tuesday, June 30th. The company reported ($3.89) EPS for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The business had revenue of $18.09 million for the quarter. On average, analysts expect that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Roble Belko & Company Inc increased its stake in shares of ChronoScale Corporation Common Stock by 104.5% in the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after buying an additional 1,195 shares during the period. Virtu Financial LLC bought a new stake in ChronoScale Corporation Common Stock in the third quarter valued at approximately $57,000. Shay Capital LLC acquired a new stake in ChronoScale Corporation Common Stock during the 3rd quarter valued at approximately $67,000. Citadel Advisors LLC acquired a new stake in ChronoScale Corporation Common Stock during the 3rd quarter valued at approximately $198,000. Finally, Geode Capital Management LLC raised its holdings in ChronoScale Corporation Common Stock by 68.9% during the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock worth $218,000 after purchasing an additional 10,281 shares during the last quarter. 6.42% of the stock is owned by institutional investors and hedge funds.
ChronoScale Corporation Common Stock Company Profile
Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.
In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.
Read More
- Five stocks we like better than ChronoScale Corporation Common Stock
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for ChronoScale Corporation Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChronoScale Corporation Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
